1.Clinical and Angiographic Outcomes: Subcutaneous Nadroparin versus Ticlopidine after Coronary Stenting.
Kyoung Deok SHIN ; Jei Keon CHAE ; Sung Ki MOON ; Won Ho KIM ; Jae Ki KO
Korean Circulation Journal 1999;29(3):259-265
BACKGROUNG AND OBJECTIVES: It was reported that low molecular weight heparin (LMWH) was more effective than unfractionated heparin in patients with acute coronary syndrome. Recent studies have shown that the pathophysiology of restenosis in stented lesions was different from those of nonstented lesions. Treatment strategies designed to limit cellular proliferation that were ineffective in nonstented lesions may be efficacious in reducing in-stent restenosis. This study was aimed to compare the clinical and angiographic results of LMWH (nadroparin) after coronary stenting with those of conventional ticlopidine regimen. MATERIALS AND METHODS: Patients were eligible for inclusion if they had angina and/or objective evidence of myocardial ischemia, and a significant (>50%) stenosis that was documented on a recent coronary angiogram. After stenting, prospective randomized comparison study was performed. Patients were randomly assigned to either nadroparin (200 IU/kg, sc, bid) or ticlopidine (250 mg bid) plus aspirin (200 mg qd) treatment groups. Repeat coronary angiography (KERN=*)was performed at 236+/-90days after stenting, and quantitative coronary angiographic analysis (QCA) was done. RESULTS: Intracoronary stent implantation was performed in eighty five lesions in eighty one patients (ticlopidine:40, nadroparin:41). There was no significant difference in any baseline clinical/angiographic variables between the two treatment groups. There were no subacute stent thrombosis, infarction and death in both groups. Six-month event-free survival was 36 (90%) in the ticlopidine group and 35 (85.4%) in the nadroparin group. Follow-up quantitative angiographic data such as late loss (1.35+/-0.70 vs 1.32+/-0.69), loss index (0.53+/-0.70 vs 0.56+/-0.23) and restenosis rate (36% vs 25.8%) were not different between ticlopidine and nadroparin groups. CONCLUSION: Effects of nadroparin were not different from those with ticlopidine therapy in the prevention of restenosis and subacute stent thorombosis after coronary stenting. Clinical outcomes between two strategies were similar. Low molecular weight heparin may be an alternative to ticlopidine in patients that ticlopidine cannot be administered because of severe adverse effects.
Acute Coronary Syndrome
;
Aspirin
;
Cell Proliferation
;
Constriction, Pathologic
;
Coronary Angiography
;
Disease-Free Survival
;
Follow-Up Studies
;
Heparin
;
Heparin, Low-Molecular-Weight
;
Humans
;
Infarction
;
Myocardial Ischemia
;
Nadroparin*
;
Prospective Studies
;
Stents*
;
Thrombosis
;
Ticlopidine*
2.A Study on the Proteins that Interact with Human Nebulin SH3 Domain.
Soo Ho CHOI ; Han Suk KO ; Deok Weon KIM
Journal of Korean Orthopaedic Research Society 2002;5(2):133-139
OBJECTIVE: bjective: By identifying the unknown substance responsible for binding with nebulin SH3 domain within the sarcomeric Z-line, we tried to find out Z-line structure which plays an important role on muscle contraction and maintenance of muscle funtion. METHOD: First, the bait plasmid was made by binding the DNA binding domain of Gal4 protein of yeast and the SH3 domain. Second, library plasmid was made by binding activation domain and human skeletal cDNA library. Then, the base sequence of the clone, produced by combining the two proteins expressed by transgenically converted plasmid in yeast, was analyzed. RESULT: We screened out six true positive clones and analyzed the base sequence of the two of six clones. We identified them to be alpha-actinin2. CONCLUSION: We can theorize that Neublin SH3 domain and alpha-actinin2 plays a vital role for the integration of Z-line. Thus, this is an important data in further studying muscle functions, mechanisms, and muscular disease as well.
Base Sequence
;
Clone Cells
;
DNA
;
Gene Library
;
Humans*
;
Muscle Contraction
;
Muscular Diseases
;
Plasmids
;
src Homology Domains*
;
Yeasts
3.Corpus Callosotomy for Intractable Epilepsy in Children: Seizure Outcome and Prognostic Factors.
Kyung Min KIM ; Deok Soo KIM ; Tae Sung KO ; Jung Kyo LEE ; Jeong Ho KIM
Journal of Korean Epilepsy Society 2001;5(1):52-58
PURPOSE: The therapeutic effectiveness of callosotomy in controlling medically intractable epilepsy has been discussed since first case reported. Nevertheless, patient selection, type of seizures and epileptic syndromes are now better determined. We reviewed the outcome of corpus callosotomy in 20 pediatric patients and tried to identify factors associated with good outcome. METHODS: The medical records of all pediatric patients who underwent corpus callosotomy at Asan medical center between 1996 and 2000 were retrospectively analyzed. RESULTS: At the time of last follow-up, four patients(20%) became seizure free, fifteen patients(75%) had significant improvement in seizure control, and two patients(10%) remained unchanged. No significant association was found between seizure outcome and age at operation, or duration of seizure, intracranial pathology, or extent of callosal section. Drop attacks are most likely to be benefited by callosotomy in view of the frequency of seizure. This was followed by generalized tonic-clonic and myoclonic seizures. Complex partial seizures had the worst response. CONCLUSIONS: Corpus callosotomy is valuable for controlling medically intractable generalized seizures in appropriate patients. Overall, drop attacks were one of the most frequent seizure pattern and they were also most likely to be benefited from corpus callosotomy. Though most patients do not become seizure-free after corpus callosotomy, worthwhile palliation of an otherwise intractable illness can be achieved. An analysis of prognostic factors should lead to better selection of patients for surgery.
Child*
;
Chungcheongnam-do
;
Epilepsy*
;
Follow-Up Studies
;
Humans
;
Medical Records
;
Pathology
;
Patient Selection
;
Retrospective Studies
;
Seizures*
;
Syncope
4.The effect of intrapleural injection of bupivacaie for pain relief following thoracotomy.
Young Ho KO ; Deok Young CHOI ; Kyung Jun WON ; Young Jin KIM ; Dong Suep SOHN ; Dai Yun CHO ; Ki Min YANG
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(7):538-542
No abstract available.
Thoracotomy*
5.Esophageal perforation: 6 case report.
Young Jin KIM ; Young Ho KO ; Kyoung Jun WON ; Deok Young CHOI ; Dong Suep SOHN ; Dai Yun CHO ; Ki Min YANG
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(8):661-663
No abstract available.
Esophageal Perforation*
6.Evaluation of the periodontal regenerative properties of patterned human periodontal ligament stem cell sheets.
Joong Hyun KIM ; Seok Yeong KO ; Justin Ho LEE ; Deok Ho KIM ; Jeong Ho YUN
Journal of Periodontal & Implant Science 2017;47(6):402-415
PURPOSE: The aim of this study was to determine the effects of patterned human periodontal ligament stem cell (hPDLSC) sheets fabricated using a thermoresponsive substratum. METHODS: In this study, we fabricated patterned hPDLSC sheets using nanotopographical cues to modulate the alignment of the cell sheet. RESULTS: The hPDLSCs showed rapid monolayer formation on various surface pattern widths. Compared to cell sheets grown on flat surfaces, there were no significant differences in cell attachment and growth on the nanopatterned substratum. However, the patterned hPDLSC sheets showed higher periodontal ligamentogenesis-related gene expression in early stages than the unpatterned cell sheets. CONCLUSIONS: This experiment confirmed that patterned cell sheets provide flexibility in designing hPDLSC sheets, and that these stem cell sheets may be candidates for application in periodontal regenerative therapy.
Cues
;
Extracellular Matrix
;
Gene Expression
;
Humans*
;
Periodontal Ligament*
;
Pliability
;
Regeneration
;
Stem Cells*
;
Tissue Engineering
7.Pseudocirrhosis of Breast Cancer Metastases to the Liver Treated by Chemotherapy.
Su Lim LEE ; Eun Deok CHANG ; Sae Jung NA ; Jeong Soo KIM ; Ho Jung AN ; Yoon Ho KO ; Hye Sung WON
Cancer Research and Treatment 2014;46(1):98-103
Pseudocirrhosis refers to a condition that shows changes in hepatic contour that mimic cirrhosis radiographically in the absence of the typical histopathological findings of cirrhosis. This condition has been observed in patients with cancer metastatic to the liver, both in those who have undergone prior systemic chemotherapy and those who have not. Pseudocirrhosis may cause difficulty in interpretation of the response to chemotherapy and hepatic decompression and complication of portal hypertension have a negative effect on the prognosis. We report on a case of breast cancer with liver metastases that showed cirrhotic changes during disease progression. Progression of liver metastases was confirmed by F18 fluorodeoxyglucose positron emission tomography/computed tomography (PET-CT). We also performed ultrasound-guided liver biopsy and confirmed tumor infiltration with severe desmoplastic fibrosis. This case suggests the pathogenesis of pseudocirrhosis through histopathological findings and the role of PET-CT in evaluation of the response to chemotherapy in patients with pseudocirrhosis.
Biopsy
;
Breast Neoplasms*
;
Breast*
;
Decompression
;
Disease Progression
;
Drug Therapy*
;
Electrons
;
Fibrosis
;
Humans
;
Hypertension, Portal
;
Liver*
;
Neoplasm Metastasis*
;
Prognosis
8.Pseudocirrhosis of Breast Cancer Metastases to the Liver Treated by Chemotherapy.
Su Lim LEE ; Eun Deok CHANG ; Sae Jung NA ; Jeong Soo KIM ; Ho Jung AN ; Yoon Ho KO ; Hye Sung WON
Cancer Research and Treatment 2014;46(1):98-103
Pseudocirrhosis refers to a condition that shows changes in hepatic contour that mimic cirrhosis radiographically in the absence of the typical histopathological findings of cirrhosis. This condition has been observed in patients with cancer metastatic to the liver, both in those who have undergone prior systemic chemotherapy and those who have not. Pseudocirrhosis may cause difficulty in interpretation of the response to chemotherapy and hepatic decompression and complication of portal hypertension have a negative effect on the prognosis. We report on a case of breast cancer with liver metastases that showed cirrhotic changes during disease progression. Progression of liver metastases was confirmed by F18 fluorodeoxyglucose positron emission tomography/computed tomography (PET-CT). We also performed ultrasound-guided liver biopsy and confirmed tumor infiltration with severe desmoplastic fibrosis. This case suggests the pathogenesis of pseudocirrhosis through histopathological findings and the role of PET-CT in evaluation of the response to chemotherapy in patients with pseudocirrhosis.
Biopsy
;
Breast Neoplasms*
;
Breast*
;
Decompression
;
Disease Progression
;
Drug Therapy*
;
Electrons
;
Fibrosis
;
Humans
;
Hypertension, Portal
;
Liver*
;
Neoplasm Metastasis*
;
Prognosis
9.Protease-Activated Receptor-2 Is Associated with Terminal Differentiation of Epidermis and Eccrine Sweat Glands.
Yong Sup SHIN ; Hyung Won KIM ; Chang Deok KIM ; Hyun Woo KIM ; Jin Woon PARK ; Sunggyun JUNG ; Jeung Hoon LEE ; Young Kwon KO ; Young Ho LEE
Annals of Dermatology 2015;27(4):364-370
BACKGROUND: Protease-activated receptor 2 (PAR-2) participates in various biological activities, including the regulation of epidermal barrier homeostasis, inflammation, pain perception, and melanosome transfer in the skin. OBJECTIVE: To evaluate the basic physiological role of PAR-2 in skin. METHODS: We investigated PAR-2 expression in human epidermis, skin tumors, and cultured epidermal cells using western blot and immunohistochemical analysis. Additionally, we examined the effect of the PAR-2 agonist, SLIGRL-NH2, on cultured keratinocytes. RESULTS: Strong PAR-2 immunoreactivity was observed in the granular layer of normal human skin and the acrosyringium of the eccrine sweat glands. In contrast, weak PAR-2 immunoreactivity was seen in the granular layer of callused skin and in the duct and gland cells of the eccrine sweat glands. Interestingly, PAR-2 immunoreactivity was very weak or absent in the tumor cells of squamous cell carcinoma (SCC) and syringoma. PAR-2 was detected in primary keratinocytes and SV-40T-transformed human epidermal keratinocytes (SV-HEKs), an immortalized keratinocyte cell line, but not in SCC12 cells. SV-HEKs that were fully differentiated following calcium treatment displayed higher PAR-2 expression than undifferentiated SV-HEKs. Treatment of cultured SV-HEKs with PAR-2 agonist increased loricrin and filaggrin expression, a terminal differentiation marker. CONCLUSION: Our data suggest that PAR-2 is associated with terminal differentiation of epidermis and eccrine sweat glands.
Blotting, Western
;
Bony Callus
;
Calcium
;
Carcinoma, Squamous Cell
;
Cell Line
;
Epidermis*
;
Homeostasis
;
Humans
;
Inflammation
;
Keratinocytes
;
Melanosomes
;
Pain Perception
;
Receptor, PAR-2
;
Skin
;
Sweat Glands*
;
Sweat*
;
Syringoma
10.Diffusion-Weighted MR Images for Hyperacute Cerebral Infarction: Design of a Quick Volume Estimation Method for Hyperintensities.
Myung Su KO ; Deok Hee LEE ; Seong Ho PARK ; Hae Wook PYUN ; Jeong Hyun LEE ; Choong Gon CHOI ; Sang Joon KIM ; Dae Chul SUH
Journal of the Korean Radiological Society 2007;57(1):7-14
PURPOSE: To design a reliable and quick lesion volume estimation method for hyperintensities on diffusion-weighted images (DWI) for the evaluation of hyperacute stroke. MATERIALS AND METHODS: Twenty patients with obvious high signal lesions seen on DWI in the middle cerebral artery territory due to acute ischemia were enrolled to evaluate the performance of four tentatively designed semi-quantitative methods: the 25-area method, the 20-area method, the 10-area method, and the modified 10-area method. Two radiologists performed the volume analyses using these methods. Intraclass correlation coefficients were calculated to compare the correlation between the reference values and the measured values and to evaluate the interobserver agreement of each method. RESULTS: For the correlation between the measured value and the reference value, the performance of the modified 10-area method was the most powerful, with a value of 0.8981 and 0.8090 for observer 1 and 2, respectively. The interobserver agreement was satisfactory for both the 25-area method and the modified 10-area method, with a value of 0.9212 (95% CI: 0.8123-0.9681) and 0.9063 (95% CI: 0.7790-0.9618), respectively. CONCLUSION: The performance of the modified 10-area method was satisfactory for both lesion volume estimation and interobserver correlation in the evaluation of an acute cerebral infarction by the use of DWI.
Cerebral Infarction*
;
Humans
;
Ischemia
;
Middle Cerebral Artery
;
Reference Values
;
Stroke